Venture Partners at CU Boulder News
This year's LVC winners included SickStick, Exocure Therapeutics, Programmable Gectosomes, Ultrathin Endoscopes, iFeather, Octave Photonics and Theia.
A two-year, $2 million National Cancer Institute (NCI) award to Boulder-based startup SuviCa, Inc.—co-founded by CU Boulder and CU Cancer Center investigator, Tin Tin Su—hopes to find drugs that augment the effect of radiation to keep cancer at bay.
The two-day Lab Venture Challenge showcase is the can't-miss event of the year to see CU Boulder's next wave of breakthrough innovations. Register now to hear from the faculty founders of Earable, iFeather and more.
Inscripta, Inc., has announced the launch of the Onyx™ Digital Genome Engineering platform, which enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully automated workflow.
The Innosphere Fund announced their second investment in Boulder-based medical device startup company, Aspero Medical, Inc. Aspero has developed the APTM Balloon Overtube for use in gastrointestinal (GI) balloon endoscopy procedures.
On August 17, eight University of Colorado startups founded on faculty research traveled to Silicon Valley for a day-long retreat with CU Boulder alumni investors and friends.
A low-cost, high-performance battery chemistry developed by CU Boulder researchers could one day lead to scalable grid-level storage for wind and solar energy.
“We’ve observed, looking at industry-sponsored funding over the last five years, that on average 25% of it comes from our own start-ups,” says Brynmor Rees, assistant vice chancellor for research and innovation, and managing director of Venture Partners at CU Boulder.
A new drug therapy for cancer treatment, spun out of research performed in a CU Boulder biochemistry lab, may provide better results for patients with solid cancers and hematologic cancers, such as leukemia and lymphoma.
The inaugural Research-to-Market (R2M) program—hosted by Venture Partners at CU Boulder—guided researchers-turned-startup founders through the iterative process of finding a product-market fit and refining a value proposition for their respective technologies.